435 related articles for article (PubMed ID: 29683098)
1. Untargeted Metabolomics in the Discovery of Novel Biomarkers and Therapeutic Targets for Atherosclerotic Cardiovascular Diseases.
Dang VT; Huang A; Werstuck GH
Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):166-175. PubMed ID: 29683098
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Metabolomic Profiling and Incident Cardiovascular Disease: A Systematic Review.
Ruiz-Canela M; Hruby A; Clish CB; Liang L; Martínez-González MA; Hu FB
J Am Heart Assoc; 2017 Sep; 6(10):. PubMed ID: 28963102
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics in cardiovascular diseases.
Kordalewska M; Markuszewski MJ
J Pharm Biomed Anal; 2015 Sep; 113():121-36. PubMed ID: 25958299
[TBL] [Abstract][Full Text] [Related]
4. Circulating cell-derived microparticles as biomarkers in cardiovascular disease.
Thulin Å; Christersson C; Alfredsson J; Siegbahn A
Biomark Med; 2016 Sep; 10(9):1009-22. PubMed ID: 27586235
[TBL] [Abstract][Full Text] [Related]
5. Translational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment.
Dona AC; Coffey S; Figtree G
Eur J Prev Cardiol; 2016 Oct; 23(15):1578-89. PubMed ID: 27103630
[TBL] [Abstract][Full Text] [Related]
6. The Emerging Role of Metabolomics in the Diagnosis and Prognosis of Cardiovascular Disease.
Ussher JR; Elmariah S; Gerszten RE; Dyck JR
J Am Coll Cardiol; 2016 Dec; 68(25):2850-2870. PubMed ID: 28007146
[TBL] [Abstract][Full Text] [Related]
7. Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
Lackland DT; Elkind MS; D'Agostino R; Dhamoon MS; Goff DC; Higashida RT; McClure LA; Mitchell PH; Sacco RL; Sila CA; Smith SC; Tanne D; Tirschwell DL; Touzé E; Wechsler LR; ; ; ; ; ;
Stroke; 2012 Jul; 43(7):1998-2027. PubMed ID: 22627990
[TBL] [Abstract][Full Text] [Related]
8. Chronic Diseases and Lifestyle Biomarkers Identification by Metabolomics.
Mastrangelo A; Barbas C
Adv Exp Med Biol; 2017; 965():235-263. PubMed ID: 28132183
[TBL] [Abstract][Full Text] [Related]
9. Blood-Derived Lipid and Metabolite Biomarkers in Cardiovascular Research from Clinical Studies: A Recent Update.
Kale D; Fatangare A; Phapale P; Sickmann A
Cells; 2023 Dec; 12(24):. PubMed ID: 38132115
[TBL] [Abstract][Full Text] [Related]
10. Proteomics and metabolomics in biomarker discovery for cardiovascular diseases: progress and potential.
Tuñón J; Barbas C; Blanco-Colio L; Burillo E; Lorenzo Ó; Martín-Ventura JL; Más S; Rupérez FJ; Egido J
Expert Rev Proteomics; 2016 Sep; 13(9):857-71. PubMed ID: 27459711
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel cardiovascular disease associated metabolites using untargeted metabolomics.
Tabrez S; Shait Mohammed MR; Jabir NR; Khan MI
Biol Chem; 2021 May; 402(6):749-757. PubMed ID: 33951765
[TBL] [Abstract][Full Text] [Related]
12. Identifying novel biomarkers for cardiovascular disease risk prediction.
Ge Y; Wang TJ
J Intern Med; 2012 Nov; 272(5):430-9. PubMed ID: 22950687
[TBL] [Abstract][Full Text] [Related]
13. Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts.
Floegel A; Kühn T; Sookthai D; Johnson T; Prehn C; Rolle-Kampczyk U; Otto W; Weikert C; Illig T; von Bergen M; Adamski J; Boeing H; Kaaks R; Pischon T
Eur J Epidemiol; 2018 Jan; 33(1):55-66. PubMed ID: 29181692
[TBL] [Abstract][Full Text] [Related]
14. Linking of metabolomic biomarkers with cardiometabolic health in Chinese population.
Sun L; Li H; Lin X
J Diabetes; 2019 Apr; 11(4):280-291. PubMed ID: 30239137
[TBL] [Abstract][Full Text] [Related]
15. Urine protein biomarkers for detection of cardiovascular disease and their use for the clinic.
Röthlisberger S; Pedroza-Diaz J
Expert Rev Proteomics; 2017 Dec; 14(12):1091-1103. PubMed ID: 29041828
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics signature improves the prediction of cardiovascular events in elderly subjects.
Rizza S; Copetti M; Rossi C; Cianfarani MA; Zucchelli M; Luzi A; Pecchioli C; Porzio O; Di Cola G; Urbani A; Pellegrini F; Federici M
Atherosclerosis; 2014 Feb; 232(2):260-4. PubMed ID: 24468136
[TBL] [Abstract][Full Text] [Related]
17. A score including ADAM17 substrates correlates to recurring cardiovascular event in subjects with atherosclerosis.
Rizza S; Copetti M; Cardellini M; Menghini R; Pecchioli C; Luzi A; Di Cola G; Porzio O; Ippoliti A; Romeo F; Pellegrini F; Federici M
Atherosclerosis; 2015 Apr; 239(2):459-64. PubMed ID: 25687272
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Profile for Prediction of Ischemic Stroke in Chinese Hypertensive Population.
Guo X; Li Z; Zhou Y; Yu S; Yang H; Zheng L; Liu Y; Sun Y
J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1062-1069. PubMed ID: 30642666
[TBL] [Abstract][Full Text] [Related]
19. The relationship between inflammatory and oxidative stress biomarkers, atherosclerosis and rheumatic diseases.
Şerban C; Drăgan S
Curr Pharm Des; 2014; 20(4):585-600. PubMed ID: 23565633
[TBL] [Abstract][Full Text] [Related]
20. The complementary roles of imaging and 'omics' for future anti-atherosclerotic drug development.
Puri R; Nissen SE
Curr Pharm Des; 2013; 19(33):5963-71. PubMed ID: 23438963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
